MetLife Investment Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26,356
| Closed | -$238K | – | 2954 |
|
|
2024
Q1 | $238K | Hold |
26,356
| – | – | ﹤0.01% | 2095 |
|
|
2023
Q4 | $286K | Hold |
26,356
| – | – | ﹤0.01% | 2031 |
|
|
2023
Q3 | $212K | Hold |
26,356
| – | – | ﹤0.01% | 2172 |
|
|
2023
Q2 | $286K | Buy |
+26,356
| New | +$286K | ﹤0.01% | 2046 |
|
|
2022
Q2 | – | Sell |
-20,363
| Closed | -$190K | – | 2922 |
|
|
2022
Q1 | $190K | Buy |
20,363
+7,928
| +64% | +$74.1K | ﹤0.01% | 2381 |
|
|
2021
Q4 | $148K | Hold |
12,435
| – | – | ﹤0.01% | 2246 |
|
|
2021
Q3 | $142K | Hold |
12,435
| – | – | ﹤0.01% | 2278 |
|
|
2021
Q2 | $223K | Hold |
12,435
| – | – | ﹤0.01% | 2095 |
|
|
2021
Q1 | $192K | Buy |
12,435
+480
| +4% | +$7.43K | ﹤0.01% | 2074 |
|
|
2020
Q4 | $146K | Sell |
11,955
-1
| -0% | -$12 | ﹤0.01% | 2137 |
|
|
2020
Q3 | $154K | Buy |
11,956
+1,052
| +10% | +$13.5K | ﹤0.01% | 2014 |
|
|
2020
Q2 | $111K | Buy |
+10,904
| New | +$111K | ﹤0.01% | 2208 |
|
|
2018
Q4 | – | Sell |
-4,669
| Closed | -$187K | – | 2602 |
|
|
2018
Q3 | $187K | Buy |
+4,669
| New | +$187K | ﹤0.01% | 2127 |
|